Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Trial of Prostate Radiotherapy In High Risk and Node Positive Disease Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)

NCT03561961 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT03561961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Trial of Prostate Radiotherapy In High Risk and Node Positive Disease Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
Lead sponsor
Tata Memorial Centre
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 24, 2018
Completion date
March 31, 2035
Enrollment
526 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma